Fundeni Centre for Immunogenetics & Virology

Slides:



Advertisements
Similar presentations
Tumor Markers Lecture one By Dr. Reem Sallam. Objectives  To briefly introduce cancers, their incidence, some common terms, and staging system.  To.
Advertisements

Carcinogenesis Stages & Mechanisms. Eva Szabo & Gail L. Shaw
 2013 Genentech USA, Inc. All rights reserved. Disclosure/Disclaimer The Molecular Biomarkers in Cancer (MBiC) slide presentation is not an independent.
Cancer Genetics Is Cancer a Genetic Disease? Cancer is not a classic genetic disease, instead, Genetic background (set-up) has a definite role in cancer.
Prostate cancer: early detection, monitoring and prognosis: Essex Biomedical Sciences Institute (EBSI) Elena Klenova, University of Essex the search for.
Cancer.
Tumor Markers Lecture one By Dr. Waheed Al-Harizi.
Hallmarks of Cancer Six fundamental changes 1.Self sufficiency in growth factors 2.Insensitivity to growth-inhibitory signals 3.Evasion of apoptosis 4.Limitless.
KRAS testing in colorectal cancer: an overview. 2 What is KRAS? KRAS is a gene that encodes one of the proteins in the epidermal growth factor receptor.
Therapeutic Implications and Prognostic Significance of c-Met in Esophageal Squamous Cell Cancer Ching Tzao 1, Chun-Ya Wang 1, Ban-Hen Chen 1, Guang-Huan.
HUMAN IMMUNODEFICIENCY VIRUS-1 TAT PROTEIN UPREGULATES IL-6 AND IL-8 EXPRESSION IN HUMAN BREAST CANCER CELLS Yong Woo Lee 1, Natasha Kyprianou 1, Avindra.
What is Cancer? How it occurs and cell cycle regulation.
Comprehensive Gene Expression Analysis of Prostate Cancer Reveals Distinct Transcriptional Programs Associated With Metastatic Disease Kevin Paiz-Ramirez.
Objectives: Our first segment focused in the anatomy and functions of the prostate gland, to get a clear understanding of the male Genito-Urinary System.
CANCER. THE WORD CANCER  FEAR  DEATH  PAIN  SUFFERING  LOSS  ECONOMIC LOSS  DISFIGUREMENT  WHAT’S THE FUTURE.
Eleni Galani Medical Oncologist
Tumor Markers By: dr. hassan el-banna.
Cancer: when our own cells become the enemy
Amplification of COPS3 in High-grade Osteosarcoma: Relationship to TP53 Mutation and Patient Outcome Samuel Lunenfeld Research Institute Mount Sinai Hospital,
Investigating the genetic instability and expression of four DNA repair related proteins in the peripheral lymphocytes of 36 untreated lung cancer patients.
Copyright © 2006 Pearson Education, Inc. publishing as Benjamin Cummings.
Tumor Biomarkers are high lightened Once Again Cancer Facts Cancer etiology Tumor Genetics Tumor MarkersLocation Classification Uses methods of detection.
The Need for Organ Site Specific Cancer Research John T Isaacs Chemical Therapeutic Program Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
1.Nowell, PC. The clonal evolution of tumor cell populations. Science (1976) 194: Cavenee, WK & White, RL. The genetic basis of cancer. Scientific.
Dr. Ziad W Jaradat Cancer Stem Cells. Recently biologically distinct and relatively rare populations of tumor-initiating cells have been identified in.
Role of Biomarkers in Management of Prostate Cancer Dr. Angela Amayo Specialist Pathologist 13 th April 2012.
Changes in Tumor Growth and Metastatic Capacities of J82 Human Bladder Cancer Cells Suppressed by Down-regulation of Calreticulin Expression Speaker: Yi-Chien.
SC121 Unit Three Karma Pace, MS AIM: kpacemcduffy.
Metastatic Cancer – Gross Pathology Lymph node - metastasis from breastLiver – metastasis from lung Vertebral column – metastasis from prostate Mesentery.
Human Biology Sylvia S. Mader Michael Windelspecht
S. Fuessel 1, S. Unversucht 1, R. Koch 2, G. Baretton 3, A. Lohse 1, S. Tomasetti 1, M. Haase 3, M. Toma 3, M. Froehner 1, A. Meye 1, M.P. Wirth 1 1 Department.
Tumor markers Present; by Dr. Andalib Isfahan Medical School
Tumor Markers.
4. DPKK Workshop in Bonn/Königswinter Quantitative multi-gene expression analyses on paired prostate tissue samples from radical prostatectomies.
INCREASED EXPRESSION OF PROTEIN KINASE CK2  SUBUNIT IN HUMAN GASTRIC CARCINOMA Kai-Yuan Lin 1 and Yih-Huei Uen 1,2,3 1 Department of Medical Research,
SP Cancer Metastasis Summary Hypothesis: We hypothesize that miRNAs regulate breast cancer cell invasiveness and metastasis by synergistically targeting.
Arrays for Point-of-Care Early Cancer Detection James F. Rusling Departments of Chemistry & Cell Biology University of Connecticut and UCHC Storrs, CT,
Aging and Reactive oxygen Species. Aging: What is it?  Aging, has been termed generally as a progressive decline in the ability of a physiological process.
Overexpression of Serine Proteases in Ovarian Cancer Shelley Campeau Cellular and Developmental Biology Major University of California at Santa Barbara.
Author: Cheng-Chi Wang, Chi-Huey Wong
Biochemical markers for diagnosis of diseases and follow up Dr. Rana Hasanato Associate professor and consultant Head of clinical chemistry department.
Blood and Tissue Based Molecular Signatures in Predicting Prostate Cancer Progression Tarek A. Bismar, MD Professor, University of Calgary Departments.
Cancer Accelerated Biology. Learning Objectives The different methods of diagnosing cancer. The difference between a malignant tumor and a benign tumor.
Biochemical markers for diagnosis and follow up of disease
Establishment and verification of miRNAs expression molecules for breast cancer and its distant metastasis Yanhong Gao Associate Professor Department of.
Tumor Markers.
BIOLOGICAL MARKERS OF PROGNOSIS IN EWING'S SARCOMA: THE ROLE OF GAL3BP CTOS meeting, Seattle 2007 Katia Scotlandi, Diana Zambelli, Monia Zuntini, and Piero.
Cancer Antigen 15-3 Alison Nolan DT204/2. What is Cancer?  Cancer is a disease which is characterized by uncontrolled proliferation of cells.  This.
Molecular Biomarkers & Targets an overview Michael Messenger NIHR Diagnostic Evidence Co-Operative & Leeds Cancer Research UK Centre.
정책이력 일반 현황 Telomerase reverse transcriptase (TERT) related with telomerase activity regulates tumorigenic potential of mouse embryonic stem cells Seung.
Targeting of reactive oxygen species can be a potential therapeutic strategy for cancer treatment Ying-Ray Lee 1, San-Yuan Chen 2, and Hau-Ren Chen 3 1.
INTRODUCTION & OBJECTIVES Introduction: The carcinogenesis of hepatocellular carcinoma (HCC) is a multifactorial, multistep and complex process. Its prognosis.
Yuna Jo. Introduction Prostate cancer (PCa) continues to burden the Western world with its high rates of incidence and mortality despite the.
Molecular Imaging “101” The Role of Molecular Imaging in Cancer Briefing and Roundtable Washington, DC July 22, 2008 Martin G. Pomper, MD, PhD Russell.
SURGICAL ONCOLOGY AND TUMOR MARKERS
prostate cancer protein and mRNA biomarkers
GENETIC BIOMARKERS.
MicroRNA-34a: a key regulator in the hallmarks of renal cell carcinoma
The Value of Measurement of Circulating Tumor Cells in Hepatocellular Carcinoma Nashwa Sheble, Gehan Hamdy, Moones A Obada, Gamal Y Abouria, Fatma Khalaf.
Cancer.
objectives Methods Results conclusion
Transcriptional Signature of Histone Deacetylases in Breast cancer
Telomerase: A target for cancer therapeutics
Loyola Marymount University
Biochemical markers for diagnosis of diseases and follow up
Loyola Marymount University
Loyola Marymount University
Loyola Marymount University
The Role of TIPE2 Protein in Invasive Breast Carcinoma
Presentation transcript:

Fundeni Centre for Immunogenetics & Virology Telomerase and Hepsin as prognostic factors in prostate cancer progression and metastasis Ileana Constantinescu*, Rodica Tudor*** M.Harza**, M.Manu**, G.Gluck** and I. Sinescu** Centre for Immunogenetics and Virology* Centre of Urology, Dialysis, Nephrology and Kidney Transplantation** Fundeni Clinical Institute Batistei Medical Centre***

Fundeni Centre for Immunogenetics & Virology Pecorino L. Molecular Biology of Cancer, Mechanisms, Targets, and Therapeutics 2005, 1: 3, Oxford University Press.

The six hallmarks of cancer Fundeni Centre for Immunogenetics & Virology The six hallmarks of cancer Unlimited replicative potential Altered regulation of telomere maintenance results in unlimited replicative potential Angiogenesis (formation of new blood vessels) Invasion and metastasis The movement of cancer cells to other parts of the body is a major cause of cancer deaths Mutations alter the activity of enzymes involved in invasion and alter molecules involved in cell-cell and cetlextracellular adhesion Pecorino L. Molecular Biology of Cancer, Mechanisms, Targets, and Therapeutics 2005, 1: 3, Oxford University Press.

Fundeni Centre for Immunogenetics & Virology Introduction Prostate cancer is the most common male malignancy and the second leading cause of male cancer death; therefore is a great demand for noninvasive assay for early detection of prostate cancer. Working prostate tumor samples is very dificult because the malignancy is heterougenous and multifocal and early-stage tumors are nonpalpable. On the contrary, exfoliated cells representthe cancer status of the entire gland better due to the general tendency of cancer cells to exfoliate into biological fluids. One of the aim of this research is to clarify whether quantitative analysis of telomerase activity in exfoliated cells in urine could serve as a reliable molecular marker of prostate malignancy. The second aspect of interest is that prostate cancer related deaths are associated with metastasis. However, little is known about the mechanisms of this process. Hepsin is a cell surface serine protease that is markedly upregulated in human prostate cancer; however, the functional significance of this upregulationis unknown. There are scientific evidence that hepsin overexpression in prostate epithelium in vivo causes disorganization of the basement membrane. Botchkina G.I, Kim R.H, Botchkina I.L, Kirshenbaum A, Frisher Z, Adler H.L Noninvasive Detection of Prostate Cancer by Quantitative Analysis of Telomerase Activity, Clin Cancer Res, 2005;11 (9) 1.

Gene structure Fundeni Centre for Immunogenetics & Virology Pecorino L. Molecular Biology of Cancer, Mechanisms, Targets, and Therapeutics 2005, 1: 3, Oxford University Press.

Types of mutation Fundeni Centre for Immunogenetics & Virology Pecorino L. Molecular Biology of Cancer, Mechanisms, Targets, and Therapeutics 2005, 1: 3, Oxford University Press.

Fundeni Centre for Immunogenetics & Virology Material and Methods We have selected 58 patients with biopsy proven prostate cancer (N=38), with elevated total PSA levels and also with normal PSA levels. We have also included patients with PBH (N=20).There were included patients with (N=8) and without metastatsis (N=30). For the assessment of PSA we have used Microparticle Enzyme ImmunoAssay (MEIA) AxSym, ABBOTT. Telomerase was worked by PCR and Hepsin by real time PCR. Quantitative ELISA was used for the measurement of serum neopterin.

Fundeni Centre for Immunogenetics & Virology Results In all patients with elevated total PSA levels both telomerase and hepsin genes over expression were found. These values were directly correlated with significantly high serum of neopterin levels. In some patients with normal PSA levels we have noticed significantly raised telomerase gene expression. In some patients with normal PSA neopterin levels were normal. In patients with metastasis hepsin gene overexpression was noticed. A small percentage of patients without metastasis had hepsin overexpression as well.

HighTelomerase Prostate Cancer Activity (TA) 100% N=38 Fundeni Centre for Immunogenetics & Virology HighTelomerase Activity (TA) 100% Prostate Cancer N=38

Low TA 15% High TA 12% No Telomerase Activity 73 % Fundeni Centre for Immunogenetics & Virology Low TA 15% High TA 12% No Telomerase Activity 73 %

Fundeni Centre for Immunogenetics & Virology

Fundeni Centre for Immunogenetics & Virology

Fundeni Centre for Immunogenetics & Virology Conclusions Telomerase and hepsin are useful noninvasive markers for complete assessment of prostate cancer. Telomerase gene expression is useful for both early detection and diagnostic of prostate cancer. Hepsin is valuable for early detection of metastatic invasion in prostate cancer. Also, both markers are very useful as monitoring tools of anti cancer therapy in these patients.